Key Takeaway
Shave Gel Recalled by Pfizer by Pfizer was recalled on July 2, 1996.
Shave Gel Recalled by Pfizer
Description
Shave Gel Recalled by Pfizer NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE CONTACT: July 2, 1996 (301) 504-7908 Release # 96-157 CPSC and Pfizer Announce Shave Gel Recall WASHINGTON, D.C. - In cooperation with the U.S. Consumer Product Safety Commission (CPSC), the Consumer Health Care Group of Pfizer Inc. is announcing a voluntary recall of cans of PureSilk Shave Gel for women sold between October 1995 and June 1996. The inner liner of the can may corrode, and as a result the can may rupture, which could propel a plastic component or the gel from the can. Consumers could be injured by sharp edges of the ruptured can or by the plastic component. Pfizer is aware of 10 incidents of the cans rupturing. No injuries have been reported. Drug, grocery, and cosmetic stores sold more than 500,000 purple, seven-ounce cans of the shaving gel nationwide for between $2 and $2.50 a can. This recall does not affect the cream product for women sold under the name PureSilk Shave Cream. Consumers should stop using the shave gel immediately and discharge the shaving gel to reduce pressure within the can. Consumers should record the product's lot number, which is printed on the bottom of the container, then discard the shave gel can. To receive a free replacement certificate or a refund, consumers should send their name and address, with the container lot number, to Pfizer Consumer Health Care - Consumer Relations Dept., 235 East 42nd Street, New York, N.Y. 10017-5755. For more information, consumers should call Pfizer at (800) 723-7529. Media inquiries should be directed to Brian McGlynn or Robert Fauteux at (212) 573-7900.
Products Affected
PureSilk Shave Gel for women
ToiletriesRelated Recalls
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
July 29, 2025
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18
December 21, 2023
Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.
June 28, 2018
Frequently Asked Questions
Is this recall still active?
Check the status badge at the top of this page. "Ongoing" means the recall is still active and you should follow the remedy instructions. "Completed" or "Terminated" means the recall process has concluded, though the safety issue remains relevant for any unrepaired products.
How do I check if my product is affected?
Compare the model number, lot code, serial number, or date range listed in the recall notice with the information on your product's label or packaging. For vehicles, check your VIN at NHTSA.gov/Recalls.
What remedy is available for this recall?
Check the remedy section above or contact the manufacturer directly for current remedy options.
Where can I find the original recall notice?
This recall was issued by CPSC. You can view the original notice using the link provided above.